このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Nissan Chemical マネジメント

マネジメント基準チェック /24

Nissan Chemical'sの CEO はKojiro Kinoshitaで、 Jan2008年に任命され、の在任期間は 16.42年です。は、会社の株式の0.071%を直接所有しており、その価値は¥ 449.51M 。経営陣と取締役会の平均在任期間はそれぞれ3.8年と3.5年です。

主要情報

Kojiro Kinoshita

最高経営責任者

n/a

報酬総額

CEO給与比率	n/a
CEO在任期間	16.5yrs
CEOの所有権	0.07%
経営陣の平均在職期間	3.9yrs
取締役会の平均在任期間	3.6yrs

経営陣の近況

Recent updates

CEO（最高経営責任者

Kojiro Kinoshita (76 yo)

16.5yrs

在職期間

Mr. Kojiro Kinoshita serves as the Chief Executive Officer and Representative Director of Nissan Chemical Corporation since 2008. He serves as Chairman of the Board at of Nissan Chemical Corporation since...

リーダーシップ・チーム

名称	ポジション	在職期間	報酬	所有権
Kojiro Kinoshita	CEO & Chairman	16.5yrs	データなし	0.071% ¥ 499.5m
Shinsuke Yagi	President	3.5yrs	データなし	0.0080% ¥ 56.1m
Hideki Daimon	Sr. Managing Executive Officer	2.3yrs	データなし	0.00072% ¥ 5.1m
Hideyuki Endo	Managing Executive Officer	1.5yrs	データなし	データなし
Nobutomo Tsuruzoe	Managing Executive Officer and Head of Advanced Materials & Planning Dept.	6.5yrs	データなし	データなし
Yuji Nishida	Executive Officer & Plant Manager of Toyama Plant	no data	データなし	データなし
Takashi Honda	Senior EVP & Director	7.5yrs	データなし	0.0051% ¥ 35.7m
Motoaki Ishikawa	Senior Managing Executive Officer	no data	データなし	0.0043% ¥ 30.6m
Satoshi Kageshima	Executive Officer & Head of Intellectual Property Dept.	1.5yrs	データなし	データなし
Takeshi Matsuoka	Managing Executive Officer	5.3yrs	データなし	0.0022% ¥ 15.3m
Yuji Sato	Senior Managing Executive Officer & Head of Agricultural Chemicals Division	4.3yrs	データなし	データなし
Kawashima Wataru	Executive Officer	3.5yrs	データなし	データなし

3.9yrs

平均在職期間

61yo

平均年齢

経験豊富な経営陣: 4021の経営陣は経験豊富であると考えられます ( 3.8年の平均在職年数)。

取締役

名称	ポジション	在職期間	報酬	所有権
Kojiro Kinoshita	CEO & Chairman	22.5yrs	データなし	0.071% ¥ 499.5m
Shinsuke Yagi	President	4.1yrs	データなし	0.0080% ¥ 56.1m
Hideki Daimon	Sr. Managing Executive Officer	2.1yrs	データなし	0.00072% ¥ 5.1m
Takashi Honda	Senior EVP & Director	7.1yrs	データなし	0.0051% ¥ 35.7m
Motoaki Ishikawa	Senior Managing Executive Officer	2.1yrs	データなし	0.0043% ¥ 30.6m
Takeshi Matsuoka	Managing Executive Officer	2.1yrs	データなし	0.0022% ¥ 15.3m
Hidehito Obayashi	Independent Outside Director	5.1yrs	データなし	データなし
Noriyuki Katayama	Outside Auditor	10.1yrs	データなし	0.00072% ¥ 5.1m
Kazunori Kataoka	Independent Outside Director	4.1yrs	データなし	データなし
Kazuhiko Ohrai	Auditor	2.1yrs	データなし	0.0094% ¥ 66.3m
Nakagawa Miyuki	Independent Outside Director	3.1yrs	データなし	データなし
Takeoka Yuko	Independent Outside Director	1.5yrs	データなし	データなし

3.6yrs

平均在職期間

60yo

平均年齢

経験豊富なボード: 4021の取締役会は経験豊富であると考えられます ( 3.5年の平均在任期間)。

Nissan Chemical マネジメント

マネジメント 基準チェック /24

主要情報

経営陣の近況

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Full year 2024 earnings: Revenues and EPS in line with analyst expectations

Nissan Chemical Corporation to Report Q1, 2025 Results on Aug 09, 2024

Less than half of directors are independent

Nissan Chemical Corporation Provides Earnings Guidance for the Fiscal Year Ending March 31, 2024

Price target decreased by 7.4% to JP¥6,401

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Nissan Chemical Corporation to Report Q3, 2024 Results on Feb 09, 2024

Upcoming dividend of JP¥70.00 per share at 2.5% yield

First quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Nissan Chemical Corporation to Report Q2, 2024 Results on Nov 10, 2023

Nissan Chemical Corporation Provides Dividend Guidance for the Second Quarter and Year End of Fiscal Year Ending March 31, 2024

Full year 2023 earnings: EPS misses analyst expectations

Nissan Chemical Corporation (TSE:4021) announces an Equity Buyback for 1,250,000 shares, representing 0.89% for ¥5,000 million.

Nissan Chemical Corporation to Report Q1, 2024 Results on Aug 10, 2023

Upcoming dividend of JP¥94.00 per share at 2.7% yield

Third quarter 2023 earnings: EPS misses analyst expectations

Nissan Chemical Corporation to Report Fiscal Year 2023 Results on May 15, 2023

Nissan Chemical Corporation Provides Dividend Guidance for the Year Ending March 31, 2023

Less than half of directors are independent

Second quarter 2023 earnings: EPS misses analyst expectations

Second quarter 2023 earnings: EPS misses analyst expectations

Nissan Chemical Corporation to Report Q3, 2023 Results on Feb 10, 2023

Nissan Chemical Corporation to Report Q2, 2023 Results on Nov 11, 2022

Upcoming dividend of JP¥70.00 per share

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

Nissan Chemical Corporation Revises Dividend Guidance for the Second Quarter Ending September 30, 2022 and Year Ending March 31, 2023

Investor sentiment deteriorated over the past week

Full year 2022 earnings: EPS exceeds analyst expectations

Nissan Chemical Corporation Provides Consolidated Earnings Guidance for the First Half and Fiscal Year Ending March 31, 2023

Nissan Chemical Corporation to Report Q1, 2023 Results on Aug 08, 2022

Less than half of directors are independent

Upcoming dividend of JP¥68.00 per share

Tokyo District Court Renders Judgment on the Patent Infringement Lawsuit Concerning Edirol Capsules Against Sawai Pharmaceutical Co., Ltd., Nichi- Iko Pharmaceutical Co., Ltd. and Nissan Chemical Corporation

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

Nissan Chemical Corporation to Report Q4, 2022 Results on May 13, 2022

Second quarter 2022 earnings released: EPS JP¥52.18 (vs JP¥43.55 in 2Q 2021)

Upcoming dividend of JP¥48.00 per share

Investor sentiment improved over the past week

First quarter 2022 earnings released: EPS JP¥61.73 (vs JP¥52.37 in 1Q 2021)

Full year 2021 earnings released: EPS JP¥232 (vs JP¥210 in FY 2020)

Nissan Chemical Corporation Announces Dividend for the Full Year Ended March 31, 2021, Payable on June 28, 2021; Provides Divided Guidance for the Second Quarter Ending March 31, 2022 and Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2022

Upcoming dividend of JP¥52.00 per share

New 90-day low: JP¥5,710

Chugai Pharmaceutical Co., Ltd. Refiles Patent Infringement Lawsuit Concerning Edirol Capsules

Earnings beat expectations, revenue disappoints

Third quarter 2021 earnings released: EPS JP¥30.92 (vs JP¥20.64 in 3Q 2020)

Nissan Chemical Corporation to Report Fiscal Year 2021 Results on May 14, 2021

New 90-day high: JP¥6,480

Chugai Pharmaceutical Co., Ltd. Files Patent Infringement Lawsuit Against Nissan Chemical Corporation, Sawai Pharmaceutical Co., Ltd. and Nichi-Iko Pharmaceutical Co., Ltd

Nissan Chemical Corporation to Report Q3, 2021 Results on Feb 05, 2021

Nissan Chemical Corporation to Report Q2, 2021 Results on Nov 12, 2020

CEO（最高経営責任者

在職期間

リーダーシップ・チーム

平均在職期間

平均年齢

取締役

平均在職期間

平均年齢

マネジメント基準チェック /24